Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
about
Maintaining Genome Stability in Defiance of Mitotic DNA DamageThe Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical ApplicationsThe more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancersStat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1.Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors.Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression.Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.Centrosome amplification, chromosomal instability and cancer: mechanistic, clinical and therapeutic issues.Centrosome amplification: a suspect in breast cancer and racial disparities.Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axisExclusive destruction of mitotic spindles in human cancer cells.
P2860
Q26738970-3988FE16-7393-4293-B0DF-74F5F95E12FEQ26801133-390828BF-23DA-4704-8EAD-096EE3890F9CQ28072910-27CADB2F-693A-4519-A71F-3A8D0DBBCC93Q33654342-3A7D03F6-D0B7-4458-867A-1421F1705773Q33671140-12AC80FA-7A90-4201-9CA7-4C3852A8AD5DQ34662347-531D7276-3DDA-486B-A9E9-708FDBBB434EQ36586089-6EAC2A0F-249E-4DD0-813F-6E00706E7E10Q36961022-158A9B17-4C0B-48F2-AAB7-D13EE2A6D8C2Q37565093-74925403-30EC-4B58-8C64-C869CFFB6E04Q38662334-6523FF02-2D2E-4DE4-9320-4D781EE07734Q38780267-5AFECB30-3CB5-410A-8036-AB527E4EA4F4Q39176356-8A4930C3-48DA-48C5-AD72-4A68B5A50E14Q42290806-A668F2BD-8827-4295-98AB-80AB56F5F838
P2860
Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Quantitative multi-parametric ...... henotype, cell cycle and death
@en
Quantitative multi-parametric ...... enotype, cell cycle and death.
@nl
type
label
Quantitative multi-parametric ...... henotype, cell cycle and death
@en
Quantitative multi-parametric ...... enotype, cell cycle and death.
@nl
prefLabel
Quantitative multi-parametric ...... henotype, cell cycle and death
@en
Quantitative multi-parametric ...... enotype, cell cycle and death.
@nl
P2093
P2860
P356
P1476
Quantitative multi-parametric ...... henotype, cell cycle and death
@en
P2093
P C G Rida
P2860
P356
10.1038/CDDIS.2014.164
P577
2014-05-01T00:00:00Z